State Treasurers Accuse Gilead of Seeking ‘Unreasonable Profits’ From Remdesivir

By Sam | September 20, 2020

In a letter to Gilead Sciences, almost a dozen state treasurers accused the company of seeking “unreasonable profits” from its antiviral COVID-19 treatment remdesivir, demanding that it lower the price.
Source: Devices & Diagnostics Letter

Posted in Devices & Diagnostics Letter